Quick Answer
Biofrontera Inc. reported Net Income Loss of -$10.54 million for the year ending 2025.
- Biofrontera Inc. showed an increase of +40.7% in Net Income Loss from 2024 to 2025.
- This data is from Biofrontera Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Biofrontera Inc.'s Net Income Loss has grown by 4.1%.
- Historical annual values: Fiscal year 2025: -$10.54 million | Fiscal year 2024: -$17.76 million | Fiscal year 2023: -$20.13 million | Fiscal year 2022: -$640.0 thousand | Fiscal year 2021: -$37.71 million | Fiscal year 2020: -$10.99 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: